- Page 1/7
He likes medical device manufacturers. It seems they are taking market share in a booming market. They are well diversified. The company continues to put up great numbers.
He likes medical device manufacturers. It seems they are taking market share in a booming market. They are well diversified. The company continues to put up great numbers.
They are well diversified. Rising interest rates will be good for them. He would lean into the U.S. insurance space as he prefers a little more laser focus. Overall, he would favour investing in US financials, such as Schwab or E-Trade instead of insurance.
They are well diversified. Rising interest rates will be good for them. He would lean into the U.S. insurance space as he prefers a little more laser focus. Overall, he would favour investing in US financials, such as Schwab or E-Trade instead of insurance.
He has not done a lot of work on this company, but is aware they have been putting up monster earnings results. They are consistent earnings beaters, but when there are not on guidance, it is usually earnings lower than target. This makes the stock too risky for his conservative investments, but would consider it a speculative buy.
He has not done a lot of work on this company, but is aware they have been putting up monster earnings results. They are consistent earnings beaters, but when there are not on guidance, it is usually earnings lower than target. This makes the stock too risky for his conservative investments, but would consider it a speculative buy.
He thinks they are ideally positioned for the movement to cloud based storage. Estimates are that global cloud storage has increased by 90% over the past 18 months. They put up a good earnings surprise and are doing well.
He thinks they are ideally positioned for the movement to cloud based storage. Estimates are that global cloud storage has increased by 90% over the past 18 months. They put up a good earnings surprise and are doing well.
He does not like the materials space right now as there is no upward momentum in this sector presently. Given recent inflation trends, it is not being confirmed with upward price movements. He would not go here.
He does not like the materials space right now as there is no upward momentum in this sector presently. Given recent inflation trends, it is not being confirmed with upward price movements. He would not go here.
The technical chart is not showing any upward momentum. Policy factors and other issues are not fundamentally supportive. The sector is a bond proxy and this is not the time to be investing in this space as interest rates are moving up. He questions if the dividend is safe. This is not a defensive stock with rising interest rates, which he expects will rise to 4%. Yield 6%.
The technical chart is not showing any upward momentum. Policy factors and other issues are not fundamentally supportive. The sector is a bond proxy and this is not the time to be investing in this space as interest rates are moving up. He questions if the dividend is safe. This is not a defensive stock with rising interest rates, which he expects will rise to 4%. Yield 6%.
They completed a $5 billion buyback recently. They put up a beat on recent earnings, but there were concerns about future earnings. He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum. They have great forecasted cash flow, but watch out if they miss their guidance.
They completed a $5 billion buyback recently. They put up a beat on recent earnings, but there were concerns about future earnings. He does not like the space as there is a wall of sellers to overcome and bio-tech is running out of technical momentum. They have great forecasted cash flow, but watch out if they miss their guidance.